Rivendell Behavioral Health Services is a licensed substance use treatment provider in Bowling Green, KY, listed in the SAMHSA treatment directory. It offers hospital inpatient care with medical staff on site around the clock. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. On site detox services are available, so withdrawal can be managed before treatment begins. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves children/adolescents, young adults, adults.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
Hospital inpatient/24-hour hospital inpatientOutpatientHospital inpatient detoxificationHospital inpatient treatmentOutpatient day treatment or partial hospitalizationIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentDetoxification
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationMethamphetamines detoxificationOpioids detoxificationMedication routinely used during detoxification
Payment accepted
IHS/Tribal/Urban (ITU) fundsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than Medicaid
Ages served
Children/AdolescentsYoung AdultsAdultsSeniors
Accreditation
Hospital licensing authorityThe Joint Commission
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
1990 Louisville Road, Suite 110, Bowling Green, KY 42101
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare